{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:03:48Z","timestamp":1790730228940,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Interferon-\u03b3 (IFN\u03b3) is an important mediator of cellular immune responses, but high systemic levels of this cytokine are associated with immunopathology. IFN\u03b3 binds to its receptor (IFN\u03b3R) and to extracellular matrix (ECM) via four positively charged C-terminal amino acids (KRKR), the ECM-binding domain (EBD). Across evolution, IFN\u03b3 is not well conserved, but the EBD is highly conserved, suggesting a critical function. Here, we show that IFN\u03b3 lacking the EBD (IFN\u03b3\n                    <jats:sup>\u0394KRKR<\/jats:sup>\n                    ) does not bind to ECM but still binds to the IFN\u03b3R and retains bioactivity. Overexpression of IFN\u03b3\n                    <jats:sup>\u0394KRKR<\/jats:sup>\n                    in tumors reduced local ECM binding, increased systemic levels and induced sickness behavior, weight loss and toxicity. To analyze the function of the EBD during infection, we generated IFN\u03b3\n                    <jats:sup>\u0394KRKR<\/jats:sup>\n                    mice lacking the EBD by using CRISPR\u2013Cas9. Infection with lymphocytic choriomeningitis virus resulted in higher systemic IFN\u03b3\n                    <jats:sup>\u0394KRKR<\/jats:sup>\n                    levels, enhanced sickness behavior, weight loss and fatal toxicity. We conclude that local retention of IFN\u03b3 is a pivotal mechanism to protect the organism from systemic toxicity during prolonged immune stimulation.\n                  <\/jats:p>","DOI":"10.1038\/s41590-023-01420-5","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T12:04:52Z","timestamp":1675339492000},"page":"414-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["IFN\u03b3 binding to extracellular matrix prevents fatal systemic toxicity"],"prefix":"10.1038","volume":"24","author":[{"given":"Josephine","family":"Kemna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5424-6474","authenticated-orcid":false,"given":"Evelyne","family":"Gout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Daniau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9850-6039","authenticated-orcid":false,"given":"Kristoffer","family":"Wei\u00dfert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0385-1890","authenticated-orcid":false,"given":"Sandra","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1694-9803","authenticated-orcid":false,"given":"Ralf","family":"K\u00fchn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5339-0781","authenticated-orcid":false,"given":"Matthias","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0771-405X","authenticated-orcid":false,"given":"Christine","family":"Molenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anje","family":"Sporbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9218-6919","authenticated-orcid":false,"given":"Dario","family":"Zocholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Klopfleisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9772-0762","authenticated-orcid":false,"given":"Hugues","family":"Lortat-Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0891-9877","authenticated-orcid":false,"given":"Peter","family":"Aichele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kammertoens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3357-4321","authenticated-orcid":false,"given":"Thomas","family":"Blankenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"1420_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2004.08.020","volume":"21","author":"SM Hedrick","year":"2004","unstructured":"Hedrick, S. M. The acquired immune system: a vantage from beneath. Immunity 21, 607\u2013615 (2004).","journal-title":"Immunity"},{"key":"1420_CR2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"1420_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1084\/jem.161.1.72","volume":"161","author":"S Sakaguchi","year":"1985","unstructured":"Sakaguchi, S., Fukuma, K., Kuribayashi, K. & Masuda, T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161, 72\u201387 (1985).","journal-title":"J. Exp. Med."},{"key":"1420_CR4","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","volume":"3","author":"EA Tivol","year":"1995","unstructured":"Tivol, E. A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541\u2013547 (1995).","journal-title":"Immunity"},{"key":"1420_CR5","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1073\/pnas.91.2.614","volume":"91","author":"T Toyonaga","year":"1994","unstructured":"Toyonaga, T. et al. Chronic active hepatitis in transgenic mice expressing interferon-\u03b3 in the liver. Proc. Natl Acad. Sci. USA 91, 614\u2013618 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1420_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0092-8674(00)80047-1","volume":"98","author":"WS Alexander","year":"1999","unstructured":"Alexander, W. S. et al. SOCS1 is a critical inhibitor of interferon \u03b3 signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98, 597\u2013608 (1999).","journal-title":"Cell"},{"key":"1420_CR7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s43018-020-0038-2","volume":"1","author":"R Thibaut","year":"2020","unstructured":"Thibaut, R. et al. Bystander IFN-\u03b3 activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment. Nat. Cancer 1, 302\u2013314 (2020).","journal-title":"Nat. Cancer"},{"key":"1420_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s43018-020-0036-4","volume":"1","author":"ME Hoekstra","year":"2020","unstructured":"Hoekstra, M. E. et al. Long-distance modulation of bystander tumor cells by CD8+ T-cell-secreted IFN-\u03b3. Nat. Cancer 1, 291\u2013301 (2020).","journal-title":"Nat. Cancer"},{"key":"1420_CR9","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1172\/JCI115093","volume":"87","author":"H Lortat-Jacob","year":"1991","unstructured":"Lortat-Jacob, H., Kleinman, H. K. & Grimaud, J. A. High-affinity binding of interferon-\u03b3 to a basement membrane complex (Matrigel). J. Clin. Invest. 87, 878\u2013883 (1991).","journal-title":"J. Clin. Invest."},{"key":"1420_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-1656(88)90052-1","volume":"7","author":"H Dobeli","year":"1988","unstructured":"Dobeli, H. et al. Role of the carboxy-terminal sequence on the biological-activity of human immune interferon (IFN-\u03b3). J. Biotechnol. 7, 199\u2013216 (1988).","journal-title":"J. Biotechnol."},{"key":"1420_CR11","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1242\/jcs.113.15.2771","volume":"113","author":"PS Subramaniam","year":"2000","unstructured":"Subramaniam, P. S., Larkin, J. 3rd, Mujtaba, M. G., Walter, M. R. & Johnson, H. M. The COOH-terminal nuclear localization sequence of interferon \u03b3 regulates STAT1 \u03b1 nuclear translocation at an intracellular site. J. Cell Sci. 113, 2771\u20132781 (2000).","journal-title":"J. Cell Sci."},{"key":"1420_CR12","doi-asserted-by":"publisher","first-page":"10919","DOI":"10.1074\/jbc.273.18.10919","volume":"273","author":"R Sadir","year":"1998","unstructured":"Sadir, R., Forest, E. & Lortat-Jacob, H. The heparan sulfate binding sequence of interferon-\u03b3 increased the on rate of the interferon-\u03b3\u2013interferon-\u03b3 receptor complex formation. J. Biol. Chem. 273, 10919\u201310925 (1998).","journal-title":"J. Biol. Chem."},{"key":"1420_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.cytogfr.2009.02.006","volume":"20","author":"R Savan","year":"2009","unstructured":"Savan, R., Ravichandran, S., Collins, J. R., Sakai, M. & Young, H. A. Structural conservation of interferon \u03b3 among vertebrates. Cytokine Growth Factor Rev. 20, 115\u2013124 (2009).","journal-title":"Cytokine Growth Factor Rev."},{"key":"1420_CR14","doi-asserted-by":"publisher","first-page":"9901","DOI":"10.1073\/pnas.86.24.9901","volume":"86","author":"S Hemmi","year":"1989","unstructured":"Hemmi, S. et al. Cloning of murine interferon \u03b3 receptor cDNA: expression in human cells mediates high-affinity binding but is not sufficient to confer sensitivity to murine interferon \u03b3. Proc. Natl Acad. Sci. USA 86, 9901\u20139905 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1420_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature22311","volume":"545","author":"T Kammertoens","year":"2017","unstructured":"Kammertoens, T. et al. Tumour ischaemia by interferon-\u03b3 resembles physiological blood vessel regression. Nature 545, 98\u2013102 (2017).","journal-title":"Nature"},{"key":"1420_CR16","doi-asserted-by":"publisher","first-page":"9384","DOI":"10.1021\/ja4000867","volume":"135","author":"E Saesen","year":"2013","unstructured":"Saesen, E. et al. Insights into the mechanism by which interferon-\u03b3 basic amino acid clusters mediate protein binding to heparan sulfate. J. Am. Chem. Soc. 135, 9384\u20139390 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"1420_CR17","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1177\/002215540104900604","volume":"49","author":"CM van der Loos","year":"2001","unstructured":"van der Loos, C. M. et al. Immunohistochemical detection of interferon-\u03b3: fake or fact? J. Histochem. Cytochem. 49, 699\u2013710 (2001).","journal-title":"J. Histochem. Cytochem."},{"key":"1420_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-021-03818-3","volume":"597","author":"D Tsiantoulas","year":"2021","unstructured":"Tsiantoulas, D. et al. APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans. Nature 597, 92\u201396 (2021).","journal-title":"Nature"},{"key":"1420_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1365-2249.1991.tb02966.x","volume":"86","author":"C Ferran","year":"1991","unstructured":"Ferran, C. et al. Inter-mouse strain differences in the in vivo anti-CD3 induced cytokine release. Clin. Exp. Immunol. 86, 537\u2013543 (1991).","journal-title":"Clin. Exp. Immunol."},{"key":"1420_CR20","doi-asserted-by":"publisher","first-page":"916","DOI":"10.4049\/jimmunol.151.2.916","volume":"151","author":"J Kohler","year":"1993","unstructured":"Kohler, J. et al. IFN-\u03b3 involvement in the severity of Gram-negative infections in mice. J. Immunol. 151, 916\u2013921 (1993).","journal-title":"J. Immunol."},{"key":"1420_CR21","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1073\/pnas.1218295110","volume":"110","author":"JJ Listopad","year":"2013","unstructured":"Listopad, J. J. et al. Fas expression by tumor stroma is required for cancer eradication. Proc. Natl Acad. Sci. USA 110, 2276\u20132281 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1420_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41586-019-0988-7","volume":"567","author":"JL Mendoza","year":"2019","unstructured":"Mendoza, J. L. et al. Structure of the IFN\u03b3 receptor complex guides design of biased agonists. Nature 567, 56\u201360 (2019).","journal-title":"Nature"},{"key":"1420_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1369\/0022155420946403","volume":"69","author":"SD Vallet","year":"2021","unstructured":"Vallet, S. D., Clerc, O. & Ricard-Blum, S. Glycosaminoglycan\u2013protein interactions: the first draft of the glycosaminoglycan interactome. J. Histochem. Cytochem. 69, 93\u2013104 (2021).","journal-title":"J. Histochem. Cytochem."},{"key":"1420_CR24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fimmu.2013.00470","volume":"4","author":"DA Simon Davis","year":"2013","unstructured":"Simon Davis, D. A. & Parish, C. R. Heparan sulfate: a ubiquitous glycosaminoglycan with multiple roles in immunity. Front. Immunol. 4, 470 (2013).","journal-title":"Front. Immunol."},{"key":"1420_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/JLB.3RU0618-246R","volume":"105","author":"LE Collins","year":"2019","unstructured":"Collins, L. E. & Troeberg, L. Heparan sulfate as a regulator of inflammation and immunity. J. Leukoc. Biol. 105, 81\u201392 (2019).","journal-title":"J. Leukoc. Biol."},{"key":"1420_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.molcel.2017.05.011","volume":"66","author":"J Oyler-Yaniv","year":"2017","unstructured":"Oyler-Yaniv, J. et al. Catch and release of cytokines mediated by tumor phosphatidylserine converts transient exposure into long-lived inflammation. Mol. Cell 66, 635\u2013647 (2017).","journal-title":"Mol. Cell"},{"key":"1420_CR27","doi-asserted-by":"publisher","first-page":"16139","DOI":"10.1074\/jbc.271.27.16139","volume":"271","author":"H Lortat-Jacob","year":"1996","unstructured":"Lortat-Jacob, H., Baltzer, F. & Grimaud, J. A. Heparin decreases the blood clearance of interferon-\u03b3 and increases its activity by limiting the processing of its carboxyl-terminal sequence. J. Biol. Chem. 271, 16139\u201316143 (1996).","journal-title":"J. Biol. Chem."},{"key":"1420_CR28","first-page":"253","volume":"37","author":"H Lortat-Jacob","year":"1991","unstructured":"Lortat-Jacob, H. & Grimaud, J. A. Interferon-\u03b3 C-terminal function: new working hypothesis. Heparan sulfate and heparin, new targets for IFN-\u03b3, protect, relax the cytokine and regulate its activity. Cell Mol. Biol. 37, 253\u2013260 (1991).","journal-title":"Cell Mol. Biol."},{"key":"1420_CR29","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1126\/science.1214935","volume":"335","author":"R Medzhitov","year":"2012","unstructured":"Medzhitov, R., Schneider, D. S. & Soares, M. P. Disease tolerance as a defense strategy. Science 335, 936\u2013941 (2012).","journal-title":"Science"},{"key":"1420_CR30","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, aaf1098 (2016).","journal-title":"Science"},{"key":"1420_CR31","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1016\/j.cell.2021.05.036","volume":"184","author":"RE Niec","year":"2021","unstructured":"Niec, R. E., Rudensky, A. Y. & Fuchs, E. Inflammatory adaptation in barrier tissues. Cell 184, 3361\u20133375 (2021).","journal-title":"Cell"},{"key":"1420_CR32","doi-asserted-by":"publisher","first-page":"eaaw4361","DOI":"10.1126\/science.aaw4361","volume":"365","author":"SP Rosshart","year":"2019","unstructured":"Rosshart, S. P. et al. Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science 365, eaaw4361 (2019).","journal-title":"Science"},{"key":"1420_CR33","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1039\/b923878f","volume":"12","author":"M Jasnin","year":"2010","unstructured":"Jasnin, M. et al. Dynamics of heparan sulfate explored by neutron scattering. Phys. Chem. Chem. Phys. 12, 3360\u20133362 (2010).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"1420_CR34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/newbio242148a0","volume":"242","author":"IJ Fidler","year":"1973","unstructured":"Fidler, I. J. Selection of successive tumour lines for metastasis. Nat. New Biol. 242, 148\u2013149 (1973).","journal-title":"Nat. New Biol."},{"key":"1420_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nature03954","volume":"437","author":"G Willimsky","year":"2005","unstructured":"Willimsky, G. & Blankenstein, T. Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 437, 141\u2013146 (2005).","journal-title":"Nature"},{"key":"1420_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1012-2","volume":"17","author":"M Haeussler","year":"2016","unstructured":"Haeussler, M. et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 17, 148 (2016).","journal-title":"Genome Biol."},{"key":"1420_CR37","doi-asserted-by":"publisher","first-page":"14457","DOI":"10.1074\/jbc.M116.733154","volume":"291","author":"S Chen","year":"2016","unstructured":"Chen, S. et al. Highly efficient mouse genome editing by CRISPR ribonucleoprotein electroporation of zygotes. J. Biol. Chem. 291, 14457\u201314467 (2016).","journal-title":"J. Biol. Chem."},{"key":"1420_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","volume":"33","author":"M Battegay","year":"1991","unstructured":"Battegay, M. et al. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33, 191\u2013198 (1991).","journal-title":"J. Virol. Methods"}],"updated-by":[{"DOI":"10.1038\/s41590-023-01464-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000}},{"DOI":"10.1038\/s41590-024-01835-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000}}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01420-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01420-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01420-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T02:02:11Z","timestamp":1713578531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01420-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1420"],"URL":"https:\/\/doi.org\/10.1038\/s41590-023-01420-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742518334.793598480","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,2]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41590-023-01464-7","URL":"https:\/\/doi.org\/10.1038\/s41590-023-01464-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41590-024-01835-8","URL":"https:\/\/doi.org\/10.1038\/s41590-024-01835-8","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}